5Mast ST,Jolis JG,Ryan T,et al.The progression of fenfluramine -associated valvularheartdisease assessed by eehocardiography[J].Ann InternMed,2001,134:261-266 被引量：1
6Alicia A.Anti-obesity drugs recalled from global market[J].Lancet,1997,350(9081):867 被引量：1
7Kentrup H,Bongers H,Spengler M,et al.Efficacy and safety of acarbose in patients with cystic fibrosis and impaired glacose tolerance[J].Ear,Pediatr,1999,158(6):455-459 被引量：1
8Stock MJ.Sibutramine:A review of the pharmaeology of novel anti-obesity agent[J],Int J Obe Relat Metab Disord,1997,21(1):25 被引量：1
9Lueas KH,Kaplan-Machlis B.Orlistat-a novel weight loss therapy[J].Ann Pharmacother,2001,35(3):314-328 被引量：1
10McDuffie JR,Calis SL.Effects of orlistant on fat -solube vitamins in obese adolescentz[J].Pharmacotherapy,2002.22(7):814-822 被引量：1
